Lenvima 8 MG daily dose 60S
Ended Awarded
- Contract number
- SPE2DB25FNMXQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,708
Award facts
- Contract value 100% obligated
- $22,707.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 22, 2025, with a ceiling value of $22,707.56. The delivery order covers LENVIMA 8 mg daily dose tablets in quantities of 60 units, a prescription oncology medication used in cancer treatment. This award represents an individual delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026. The contract utilizes no set-aside designation, allowing the company to compete on its merits as a woman-owned small business in the federal procurement marketplace.
The award is scheduled for ultimate completion by October 14, 2025, and the place of performance is Park Ridge, Illinois. As a key supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established itself as a critical vendor for the Department of Defense healthcare system through its comprehensive distribution of branded and generic prescription drugs, biologics, and medical consumables. This delivery order exemplifies the company's role in supporting military health facilities' medical supply needs nationwide through the DLA's pharmaceutical procurement operations.
Quick answers
Who was awarded contract SPE2DB25FNMXQ?
SPE2DB25FNMXQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FNMXQ worth?
The government has obligated $22,708 on SPE2DB25FNMXQ.
Is contract SPE2DB25FNMXQ an order under another contract?
Yes. SPE2DB25FNMXQ is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMXQ competed?
The extent of competition for SPE2DB25FNMXQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award